IPF (Idiopathic Pulmonary Fibrosis) is a relatively uncommon disease, with an estimated incidence of 2 to 29 cases per 100,000 people per year. It is more common in individuals over the age of 50 and is slightly more common in men than women. However, it is important to note that IPF is a serious and progressive disease with no known cure, and it can significantly impact the quality of life of those affected. Early detection and treatment can help to slow down the progression of the disease and improve symptoms, so it is important for individuals who may be at risk to speak with their healthcare provider about screening and monitoring for IPF.